Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life

Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life

Cristiana Montemagni,1,2 Tiziana Frieri,1,2 Paola Rocca1,2 1Department of Neuroscience, Unit of Psychiatry, University of Turin, 2Department of Mental Health, Azienda Sanitaria Locale (ASL) Torino 1 (TO1), Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza di Tori...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Montemagni C, Frieri T, Rocca P
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
long-acting injectable antipsychotics
second-generation antipsychotics
quality of life
schizophrenia
functioning
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Acceso en línea:https://doaj.org/article/0df15e1f5c4d4621afaf1e7cf75c316f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/0df15e1f5c4d4621afaf1e7cf75c316f

Ejemplares similares